Propranolol - intranasal - Questcor
Alternative Names: MigrastatLatest Information Update: 24 Oct 2021
At a glance
- Originator Questcor Pharmaceuticals
- Class Antihypertensives; Antimigraines; Class II antiarrhythmics; Ischaemic heart disorder therapies; Naphthalenes; Propanolamines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 13 Oct 2005 Discontinued - Phase-II for Migraine in USA (Intranasal)
- 15 Jan 2003 Propranolol intranasal is available for licensing (www.questcor.com)
- 19 May 2000 Phase-II clinical trials for Migraine in USA (Intranasal)